Thomas Nusbickel, Chief Commercial Officer, Celltrion USA
Advertisement
Articles by Thomas Nusbickel, Chief Commercial Officer, Celltrion USA
Advertisement
Latest Updated Articles
- Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars
Published: July 5th 2023 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA Reviewing New Combination Therapy for Patients with MIBC
2
A Conversation With Lucille Accetta, RPh, M.P.H., MBA
3
U.S. Lung Cancer Survival Improves to Nearly 30%, but Funding Cuts Threaten Progress
4
Selling Direct
5
